Workability, Health Literacy and Quality of Life of Patients with Common Variable Immunodeficiency Syndrome - Study Phase II

Not Applicable

• Conditions: D83; Common variable immunodeficiency

• Registration Number: DRKS00012336
• Lead Sponsor: Centrum für Chronische Immundefizienz (CCI)am Zentrum für Translationale Zellforschung (ZTZ)Clinical Research Unit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-24
• Study Completion: 2018-01-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 127

Inclusion Criteria

CVID Patients who have been treated in the Center for Chronic Immunodeficiency (CCI) in Freiburg since January 1, 2012/ Patient consent declaration/ Participation in the first study phase WoHL-CVID I

Exclusion Criteria

Patient with a very high disease burden and a short life expectancy or a permanently very bad general health condition.
Not enough knowledge of the German language in spoken and written, strong cognitive restrictions.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of the effectiveness of the training developed in the first study phase.The primary endpoint is the change of the patient reported outcome Health education literacy of patients (HELP) between baseline (T0) and after four months (T1).

Secondary Outcome Measures

Name	Time	Method
1. Assessment of the satisfaction of the participants with the training.<br><br>2. Identify groups that are particularly benefiting by the training.